Tech stocks kicked off 2026 with a correction warning—software names led the decline as semiconductor valuations hit extreme levels. But beneath the volatility, two ETFs—JPMorgan U.S. Tech Leaders (JTEK) and iShares Future Exponential Technologies (XT)—are positioned to capitalize on AI-driven growth without the overconcentration risks of the Magnificent Seven. Here’s why they’re smarter bets than the SPDR S&P 500 ETF (SPY) for investors who can stomach short-term choppiness for long-term innovation exposure.
The 2026 Tech Reset: Why Software Stocks Are Flashing Warning Signs
The first trading day of 2026 sent a clear signal: software stocks are vulnerable. After a year of AI-driven euphoria, the sector led declines as investors questioned whether semiconductor valuations—pushed to historic extremes—could sustain their momentum. The Nasdaq Composite dropped 1.8% on January 2, with cloud and cybersecurity names underperforming. Meanwhile, the SPDR S&P 500 ETF (SPY) remained flat, masking the turbulence beneath the surface.
This isn’t just noise. Three critical factors are converging:
- Valuation extremes: The average semiconductor stock in the PHLX Semiconductor Index (SOX) trades at 28x forward earnings—double its 10-year median. Nvidia alone accounts for 20% of the index, creating a single-stock risk comparable to the dot-com bubble.
- Monetization lag: AI infrastructure spending is surging, but revenue growth for hyped names like C3.ai (AI) and SoundHound AI (SOUN) hasn’t kept pace. The market is betting on future profits that may take years to materialize.
- Rotation risk: With the Fed’s rate-cut cycle expected to begin mid-2026, investors may shift from growth to value—leaving overcrowded tech trades exposed.
Yet here’s the opportunity: Not all tech is created equal. While the Magnificent Seven (Apple, Microsoft, Nvidia, etc.) dominate the S&P 500, two ETFs—JTEK and XT—offer targeted exposure to high-growth innovators without the same concentration risks. Their active management and diversified holdings could outperform in a market where stock-picking matters more than passive indexing.
JPMorgan U.S. Tech Leaders ETF (JTEK): The Active Manager’s Edge
Launched in 2023, JTEK has already delivered a 77% return—double the SPY’s 38% gain over the same period. The secret? Active management that avoids the herd. While most tech ETFs are top-heavy with Apple and Microsoft, JTEK’s largest holdings are:
- Broadcom (AVGO) (6.8%) – A semiconductor play with diversified revenue streams beyond AI.
- Adobe (ADBE) (6.2%) – The creative software leader benefiting from AI-driven productivity tools.
- Robinhood (HOOD) (5.1%) – A fintech disruptor with 23 million funded accounts and expanding into crypto.
- Snowflake (SNOW) (4.7%) – The cloud data warehouse growing revenue at 30%+ annually.
Critics will balk at the 0.65% expense ratio—higher than passive funds like Vanguard’s VOO (0.03%). But for investors who believe in stock-picking over indexing, the fee is justified. JTEK’s managers are betting on:
- Mid-cap growth: 40% of the portfolio is in firms with market caps under $120 billion, where AI adoption can drive outsized returns.
- Balanced sector exposure: Unlike SOXX (pure semis) or IGV (pure software), JTEK blends hardware, software, and fintech.
- Lower volatility: The ETF’s 3-year beta is 1.1x vs. SPY’s 1.0x—less risky than you’d expect for a tech-focused fund.
Key risk: If large-cap tech rebounds, JTEK could lag due to its underweight in mega-caps. But in a market where active management is regaining favor [Bloomberg], that’s a trade-off worth considering.
iShares Future Exponential Technologies ETF (XT): The Global Innovation Play
While JTEK focuses on U.S. leaders, XT casts a wider net. This ETF tracks companies driving exponential technologies—AI, robotics, genomics, and clean energy—across developed and emerging markets. Since its 2020 launch, XT has:
- Outperformed the Nasdaq 100 in 3 of the past 4 years, including a 22% gain in 2025 vs. the Nasdaq’s 18%.
- Kept fees low at 0.46%, cheaper than 70% of global tech ETFs.
- Avoided single-stock risk: No holding exceeds 5% of the portfolio.
XT’s top holdings reveal its unique approach:
- ASML (ASML) (4.9%) – The Dutch semiconductor equipment giant enabling next-gen chips.
- Taiwan Semiconductor (TSM) (4.7%) – The world’s largest foundry, critical for AI hardware.
- Intuitive Surgical (ISRG) (4.5%) – A healthcare robotics leader with 30%+ revenue growth.
- Modern (MRNA) (4.3%) – The biotech innovator behind mRNA vaccines, now expanding into AI-driven drug discovery.
Why this matters:
- Diversification beyond FAANG: Only 30% of XT’s holdings overlap with the S&P 500.
- Healthcare + tech hybrid: 20% of the portfolio is in biotech and genomics, sectors poised to benefit from AI but often ignored by pure-tech ETFs.
- Emerging market exposure: 15% allocated to Asia-Pacific innovators like Samsung Electronics and Alibaba.
The trade-off? Higher volatility. XT’s 3-year beta is 1.3x, reflecting its focus on disruptive growth. But for investors who believe in thematic investing, that’s the point.
JTEK vs. XT vs. SPY: Which Wins in 2026?
| Metric | JTEK | XT | SPY |
|---|---|---|---|
| 2025 Return | +77% | +22% | +18% |
| Expense Ratio | 0.65% | 0.46% | 0.09% |
| Top 10 Concentration | 42% | 38% | 30% |
| AI Exposure | High (software/fintech) | Very High (semis/biotech) | Moderate (NVDA/MSFT) |
| Volatility (Beta) | 1.1x | 1.3x | 1.0x |
Best for conservative investors: Stick with SPY if you can’t handle drawdowns. But if you’re betting on AI monetization and active management’s comeback, here’s how to play it:
- For U.S.-focused growth: JTEK is the pick. Its mid-cap tilt and fintech exposure could outperform if the Fed cuts rates and consumer spending rebounds.
- For global innovation: XT wins. Its blend of semis, biotech, and robotics is unmatched in a single ETF.
- For a hybrid approach: Allocate 60% to JTEK and 40% to XT to balance U.S. growth with global disruption.
The Biggest Risk No One’s Talking About
Both ETFs face a monetization cliff: If AI spending slows before revenue materializes, high-growth stocks could crash. Watch these signals:
- Nvidia’s data center revenue: If growth drops below 20% YoY, the AI trade is in trouble.
- Cloud capex: Amazon, Microsoft, and Google’s infrastructure spending is the canary in the coal mine.
- Regulatory cracks: The EU’s AI Act and U.S. antitrust probes could stifle innovation—especially for XT’s global holdings.
Bottom line: These ETFs aren’t for the faint of heart. But if you believe in AI’s long-term transformative power and are willing to ride out volatility, they offer higher upside than the S&P 500—without betting the farm on seven overowned stocks.
How to Position Your Portfolio Now
Here’s a tactical plan for 2026:
- Trim overvalued semis: Reduce exposure to SOXX or SMH if you’re overweight. Rotate into JTEK for broader tech leadership.
- Add XT for diversification: Allocate 5–10% of your tech sleeve to XT for exposure to biotech and global innovators.
- Set stop-losses: Protect gains with a 15–20% trailing stop on both ETFs. If the Nasdaq drops below its 200-day moving average, reconsider.
- Watch the Fed: If rate cuts come sooner than expected, JTEK’s fintech holdings (HOOD, COIN) could surge.
Remember: 2026 won’t be a straight line up. The tech sector is entering a “prove it” phase, where revenue growth must justify valuations. But for investors who can stomach the ride, JTEK and XT offer a smarter way to play innovation—without the baggage of the Magnificent Seven.
For more razor-sharp analysis on where the smart money is flowing in 2026, bookmark onlytrustedinfo.com. We cut through the noise to deliver the fastest, most actionable insights—so you’re always one step ahead of the market.
